Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

Editta Baldini,Tiziana Prochilo,Barbara Salvadori,A. Bolognesi,D. Aldrighetti,M. Venturini,R. Rosso,F Carnino,L Gallo,P. G. Giannessi,Pierfranco Conte,Cinzia Orlandini,Paolo Bruzzi

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

2004

Editta Baldini
Tiziana Prochilo
Barbara Salvadori
A. Bolognesi
D. Aldrighetti
M. Venturini
R. Rosso
F Carnino
L Gallo
P. G. Giannessi
Pierfranco Conte
Cinzia Orlandini
Paolo Bruzzi

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

Keywords:

Oncology
Clinical trial
Cancer
Breast cancer
Medicine
Multicenter trial
Pathology
Epirubicin
Paclitaxel
Metastasis
Metastatic breast cancer
Internal medicine
Surgery
Ejection fraction
Cumulative dose
Heart failure
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations